Literature DB >> 20219249

Hippocampal visuospatial function and volume in remitted depressed patients: an 8-year follow-up study.

Lars B Hviid1, Barbara Ravnkilde, Jamila Ahdidan, Raben Rosenberg, Hans Stødkilde-Jørgensen, Poul Videbech.   

Abstract

BACKGROUND: Several lines of evidence suggest hippocampal dysfunction in major depression, but the prevalence and nature of specific dysfunctions during the long-term course of major depression is yet to be assessed. A 3D virtual environment navigation task and measurements of hippocampal volume were assessed in remitted former inpatients with moderate to severe depression after an 8 year follow-up period to evaluate whether functional and structural differences existed in the hippocampus beyond depression.
METHODS: Performance on a right hippocampus-dependent 3D virtual reality navigation task, memory tests and right and left hippocampal volumes were assessed in 31 remitted depressed (unipolar) patients and 37 healthy subjects.
RESULTS: Remitted depressed patients did not differ significantly from healthy subjects in terms of either neuropsychological performance or hippocampal volume. LIMITATIONS: The sample consisted of remitted inpatients that had been treated with psychotropic drugs during the 8-year follow-up period. Moreover, 11 of the 42 patients included in the original study were excluded from the follow-up study due to persisting depressive illness and suicide.
CONCLUSIONS: The study of visuospatial navigation ability and hippocampal volume in remitted depressed patients offers a specific way of assessing dysfunction in the hippocampus in major depression. Our findings do not support the notion that hippocampal impairment of visuospatial function exists beyond the depressive state, thus indicating that hippocampus-related cognitive dysfunction and previously reported reduced hippocampal volume might represent a state and not a permanent trait of the illness. Moreover, our study suggests that intensive drug treatment of the depressive episodes might prevent the deterioration of the hippocampus. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219249     DOI: 10.1016/j.jad.2010.01.002

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Volumetric brain differences in clinical depression in association with anxiety: a systematic review with meta-analysis.

Authors:  Daniela A Espinoza Oyarce; Marnie E Shaw; Khawlah Alateeq; Nicolas Cherbuin
Journal:  J Psychiatry Neurosci       Date:  2020-11-01       Impact factor: 6.186

2.  Identifying a cognitive impairment subgroup in adults with mood disorders.

Authors:  Grant L Iverson; Brian L Brooks; Scott A Langenecker; Allan H Young
Journal:  J Affect Disord       Date:  2011-03-25       Impact factor: 4.839

Review 3.  Towards automated detection of depression from brain structural magnetic resonance images.

Authors:  Kuryati Kipli; Abbas Z Kouzani; Lana J Williams
Journal:  Neuroradiology       Date:  2013-01-22       Impact factor: 2.804

4.  Edge of the Present: A Virtual Reality Tool to Cultivate Future Thinking, Positive Mood and Wellbeing.

Authors:  Stephanie Habak; Jill Bennett; Alex Davies; Michaela Davies; Helen Christensen; Katherine M Boydell
Journal:  Int J Environ Res Public Health       Date:  2020-12-28       Impact factor: 3.390

5.  Brain Activation during Memory Retrieval is Associated with Depression Severity in Women.

Authors:  Jennifer T Sneider; Julia E Cohen-Gilbert; Derek A Hamilton; Anna M Seraikas; Emily N Oot; Eleanor M Schuttenberg; Lisa D Nickerson; Marisa M Silveri
Journal:  Psychiatry Res Neuroimaging       Date:  2020-10-09       Impact factor: 2.376

6.  Epistatic Interaction Between 5-HT1A and Vascular Endothelial Growth Factor Gene Polymorphisms in the Northern Chinese Han Population With Major Depressive Disorder.

Authors:  Dong Han; Zhengxue Qiao; Dong Qi; Jiarun Yang; Xiuxian Yang; Jingsong Ma; Lin Wang; Xuejia Song; Erying Zhao; Jian Zhang; Yanjie Yang; Xiaohui Qiu
Journal:  Front Psychiatry       Date:  2019-04-16       Impact factor: 4.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.